Overview

Trazodone in Painful Diabetic Neuropathy

Status:
Completed
Trial end date:
2018-08-09
Target enrollment:
Participant gender:
Summary
The aim of the study is to collect preliminary information on the effect of low doses of trazodone on pain intensity in patients with painful diabetic neuropathy and to evaluate the neuropathic pain symptoms, anxiety, sleep, quality of life, safety and tolerability.
Phase:
Phase 2
Details
Lead Sponsor:
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborator:
Chiltern International Inc.
Treatments:
Trazodone